The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Net Asset Value(s)

19 Jun 2017 10:47

RNS Number : 4620I
Seneca Global Income & Growth PLC
19 June 2017
 

To:

RNS

From:

Seneca Global Income & Growth Trust plc

LEI:

213800OQTUSRFDIL9L29

Date:

19-Jun-17

Net Asset Values

The unaudited net asset values ("NAVs") of the Company are noted below in pence

per share. NAVs are calculated in accordance with stated policies. Applicable

accounting standards and AIC recommendations are followed.

The NAVs per ordinary share as at the close of business on: 16 June 2017:

Pence Per Share

Cum

Ex

Income

Income

171.92

171.20

For further information please contact:

Steven Cowie

Company Secretary

PATAC Limited

0131 538 1400

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVGGUQCQUPMUBB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.